Download PDF
Semin Plast Surg 2016; 30(02): 055-059
DOI: 10.1055/s-0036-1580729
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Salvage of Infected Prosthetic Breast Reconstructions

Amy S. Xue
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Katarzyna E. Kania
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Rodger H. Brown
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Jamal M. Bullocks
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Larry H. Hollier Jr.
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
,
Shayan A. Izaddoost
1   Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
04 May 2016 (online)

    Permissions and Reprints

Abstract

Periprosthetic infection is a major complication in breast reconstruction, leading to implant loss and delayed and sometimes abandoned reconstruction. Traditional management of persistent infections requires explantation followed by secondary reconstruction after 6 months of delay. Although effective in treating the infection, this approach often leads to distortion and/or loss of tissue envelope, making secondary reconstruction very difficult. As a result, there is significant interest in salvaging infected prosthetic breast reconstructions. Recent studies reported variable success through systemic antibiotic therapy and surgical interventions. The aim of this article is to review the management of periprosthetic infection and to provide a potential salvage algorithm.

Keywords

infected prosthetic breast reconstruction - periprosthetic breast infection - salvage of implant-based breast reconstruction - salvage of periprosthetic infection
 

  • References

  • 1 American Society of Plastic Surgeons. 2014 Plastic Surgery Statistics Report. 2015. Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2014-statistics/reconstructive-breast-procedures-age.pdf . Accessed October 2, 2015
    PubMedGoogle Scholar
  • 2 Bennett SP, Fitoussi AD, Berry MG, Couturaud B, Salmon RJ. Management of exposed, infected implant-based breast reconstruction and strategies for salvage. J Plast Reconstr Aesthet Surg 2011; 64 (10) 1270-1277
    CrossrefPubMedGoogle Scholar
  • 3 Peled AW, Stover AC, Foster RD, McGrath MH, Hwang ES. Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications. Ann Plast Surg 2012; 68 (4) 369-373
    CrossrefPubMedGoogle Scholar
  • 4 Berry T, Brooks S, Sydow N , et al. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol 2010; 17 (Suppl. 03) 202-210
    CrossrefPubMedGoogle Scholar
  • 5 Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 2002; 109 (7) 2265-2274
    CrossrefPubMedGoogle Scholar
  • 6 Reish RG, Damjanovic B, Austen Jr WG , et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 2013; 131 (6) 1223-1230
    CrossrefPubMedGoogle Scholar
  • 7 Albright SB, Xue AS, McKnight A , et al. Pilot study: One-step salvage of infected prosthetic breast reconstructions using antibiotic-impregnated polymethylmethacrylate plates and concurrent tissue expander exchange. Ann Plast Surg 2015; [Epub ahead of print]
    PubMedGoogle Scholar
  • 8 Halvorson EG, Disa JJ, Mehrara BJ, Burkey BA, Pusic AL, Cordeiro PG. Outcome following removal of infected tissue expanders in breast reconstruction: a 10-year experience. Ann Plast Surg 2007; 59 (2) 131-136
    CrossrefPubMedGoogle Scholar
  • 9 Perras C. The prevention and treatment of infections following breast implants. Plast Reconstr Surg 1965; 35: 649-656
    CrossrefPubMedGoogle Scholar
  • 10 Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg 1979; 63 (6) 812-816
    CrossrefPubMedGoogle Scholar
  • 11 Toranto IR, Malow JB. Atypical mycobacteria periprosthetic infections—diagnosis and treatment. Plast Reconstr Surg 1980; 66 (2) 226-228
    CrossrefPubMedGoogle Scholar
  • 12 Wilkinson TS, Swartz BE, Toranto IR. Resolution of late-developing periprosthetic breast infections without prosthesis removal. Aesthetic Plast Surg 1985; 9 (2) 79-85
    CrossrefPubMedGoogle Scholar
  • 13 Sforza M, Andjelkov K, Husein R, Zaccheddu R. Will 1-stage implant salvage after periprosthetic breast infection ever be routine? A 6-year successful experience. Aesthet Surg J 2014; 34 (8) 1172-1178
    CrossrefPubMedGoogle Scholar
  • 14 Prince MD, Suber JS, Aya-Ay ML , et al. Prosthesis salvage in breast reconstruction patients with periprosthetic infection and exposure. Plast Reconstr Surg 2012; 129 (1) 42-48
    CrossrefPubMedGoogle Scholar
  • 15 Spear SL, Seruya M. Management of the infected or exposed breast prosthesis: a single surgeon's 15-year experience with 69 patients. Plast Reconstr Surg 2010; 125 (4) 1074-1084
    CrossrefPubMedGoogle Scholar
  • 16 Yii NW, Khoo CT. Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg 2003; 111 (3) 1087-1092
    CrossrefPubMedGoogle Scholar
  • 17 Lapid O. Use of gentamicin collagen sponges for the treatment of periprosthetic breast implant infection. J Plast Reconstr Aesthet Surg 2011; 64 (12) e313-e316
    CrossrefPubMedGoogle Scholar
  • 18 Clayton JL, Bazakas A, Lee CN, Hultman CS, Halvorson EG. Once is not enough: withholding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection. Plast Reconstr Surg 2012; 130 (3) 495-502
    CrossrefPubMedGoogle Scholar
  • 19 Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough?. Plast Reconstr Surg 2010; 126 (3) 779-785
    CrossrefPubMedGoogle Scholar
  • 20 Tamboto H, Vickery K, Deva AK. Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty. Plast Reconstr Surg 2010; 126 (3) 835-842
    CrossrefPubMedGoogle Scholar
  • 21 Jacombs A, Allan J, Hu H , et al. Prevention of biofilm-induced capsular contracture with antibiotic-impregnated mesh in a porcine model. Aesthet Surg J 2012; 32 (7) 886-891
    CrossrefPubMedGoogle Scholar
  • 22 Spear SL, Howard MA, Boehmler JH, Ducic I, Low M, Abbruzzesse MR. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 2004; 113 (6) 1634-1644
    CrossrefPubMedGoogle Scholar
  • 23 Finsterbusch A, Argaman M, Sacks T. Bone and joint perfusion with antibiotics in the treatment of experimental staphylococcal infection in rabbits. J Bone Joint Surg Am 1970; 52 (7) 1424-1432
    PubMedGoogle Scholar
  • 24 Benaerts PJ, Ridler BM, Vercaeren P, Thompson JF, Campbell WB. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc Surg 1999; 7 (4) 447-450
    CrossrefPubMedGoogle Scholar
  • 25 Ostermann PA, Seligson D, Henry SL. Local antibiotic therapy for severe open fractures. A review of 1085 consecutive cases. J Bone Joint Surg Br 1995; 77 (1) 93-97
    PubMedGoogle Scholar
  • 26 Walenkamp GH, Kleijn LL, de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 1998; 69 (5) 518-522
    CrossrefPubMedGoogle Scholar
  • 27 Alonge TO, Ogunlade SO, Omololu AB, Fashina AN, Oluwatosin A. Management of chronic osteomyelitis in a developing country using ceftriaxone-PMMA beads: an initial study. Int J Clin Pract 2002; 56 (3) 181-183
    PubMedGoogle Scholar
  • 28 Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 2009; 80 (2) 193-197
    CrossrefPubMedGoogle Scholar
  • 29 Poi MJ, Pisimisis G, Barshes NR , et al. Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections. Surgery 2013; 153 (5) 673-682
    CrossrefPubMedGoogle Scholar
  • 30 Stone PA, Back MR, Armstrong PA , et al. Evolving microbiology and treatment of extracavitary prosthetic graft infections. Vasc Endovascular Surg 2008; 42 (6) 537-544
    PubMedGoogle Scholar
  • 31 Stone PA, Mousa AY, Hass SM , et al. Antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary vascular surgical site infections. J Vasc Surg 2012; 55 (6) 1706-1711
    CrossrefPubMedGoogle Scholar
  • 32 Kretlow JD, Brown RH, Wolfswinkel EM , et al. Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg 2014; 133 (1) 28e-38e
    CrossrefPubMedGoogle Scholar
  • 33 Lombardi Jr AV, Berend KR, Adams JB. Partial two-stage exchange of the infected total hip replacement using disposable spacer moulds. Bone Joint J 2014; 96-B (11, Supple A) 66-69
    CrossrefPubMedGoogle Scholar
  • 34 Hake ME, Young H, Hak DJ, Stahel PF, Hammerberg EM, Mauffrey C. Local antibiotic therapy strategies in orthopaedic trauma: Practical tips and tricks and review of the literature. Injury 2015; 46 (8) 1447-1456
    CrossrefPubMedGoogle Scholar
  • 35 Tintle SM, Forsberg JA, Potter BK, Islinger RB, Andersen RC. Prosthesis retention, serial debridement, and antibiotic bead use for the treatment of infection following total joint arthroplasty. Orthopedics 2009; 32 (2) 87
    PubMedGoogle Scholar
  • 36 Shi M, Kretlow JD, Nguyen A , et al. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials 2010; 31 (14) 4146-4156
    CrossrefPubMedGoogle Scholar
  • 37 Mountziaris PM, Shah SR, Lam J, Bennett GN, Mikos AG. A rapid, flexible method for incorporating controlled antibiotic release into porous polymethylmethacrylate space maintainers for craniofacial reconstruction. Biomater Sci 2015; 4 (1) 121-129
    PubMedGoogle Scholar
  • 38 Song EK, Seon JK, Jeong MS. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement. J Bone Joint Surg Br 2010; 92 (11) 1596-1599
    PubMedGoogle Scholar
  • 39 Dovas S, Liakopoulos V, Papatheodorou L , et al. Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty. Clin Nephrol 2008; 69 (3) 207-212
    CrossrefPubMedGoogle Scholar
  • 40 Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006; 40 (11) 2037-2042
    CrossrefPubMedGoogle Scholar